TITLE

Roche cuts controversial PCR fees, testing limits

AUTHOR(S)
Anderson, C.
PUB. DATE
January 1992
SOURCE
Nature;1/30/1992, Vol. 355 Issue 6359, p379
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports that Swiss-owned pharmaceutical company Hoffmann-La Roche, under pressure from researchers and diagnostic companies, agreed to lower its prices on its polymerase chain reaction (PCR) technology and lift restrictions on its use. The move should free the technology for widespread use in testing for paternity and genetic and infectious diseases. Charges for each test; Abbott Laboratories' alternative gene amplification technique, lisage chain reaction (LCR); More.
ACCESSION #
9203093726

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics